Likewise, primary TNBC patients’ tumor samples (CRDCA, SEM‐1, and ARI‐1) also showed increased expression of E‐cadherin, active β‐catenin, and ALDH but decreased expression of YAP and CD44 (Fig. 5C, Fig. S6). This evidence concerns the gene ARIH1 and neoplasm.